| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |